New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For VVUS;ARNA;OREX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
January 14, 2015
10:21 EDTARNAOptions with decreasing implied volatility
Subscribe for More Information
06:03 EDTARNAStocks with implied volatility below IV index mean; ORCL ARNA
Subscribe for More Information
January 13, 2015
14:30 EDTOREXOrexigen CEO says 'really pleased' with Contrave launch so far
Narachi says "engaged deeply in conversations" with potential European partners for Contrave weight loss drug. Orexigen CEO Mike Narachi speaking on CNBC.
07:42 EDTOREXJPMorgan to hold a conference
33rd Annual Healthcare Conference is being held in San Francisco on January 12-15 with webcasted company presentations to begin on January 13 at 10:30 am; not all company presentations may be webcasted. Webcast Link
06:02 EDTARNAStocks with implied volatility below IV index mean; ARNA LINE
Subscribe for More Information
January 12, 2015
10:24 EDTARNAOptions with increasing implied volatility
Options with increasing implied volatility: TLM GREK ARNA AVP
08:02 EDTARNAArena Pharmaceuticals initiates Phase 2 clinical trial evaluating ralinepag
Arena Pharmaceuticals announced the initiation of patient dosing in a Phase 2 clinical trial of ralinepag, an oral, non-prostanoid prostacyclin receptor agonist intended for the treatment of pulmonary arterial hypertension. This 22-week, randomized, double-blind and placebo-controlled Phase 2 trial will evaluate the hemodynamic and exercise capacity effects, safety and tolerability of ralinepag in up to 60 patients with PAH. During the first nine weeks of the trial, patients will be titrated to their individual tolerance level, and then sustained at this level for the remainder of the trial.
06:14 EDTARNAStocks with implied volatility below IV index mean; ARNA LINE
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use